GlassScriptPhysician profile
Theodore Miller
NPI 1598316002
$1,776.85
in general payments reported to CMS, 2019-2025
12 companies · $887 in 2025
The $887 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $250 · 2023: $309 · 2024: $108 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $789.99 | 2021-2025 | Apretude, Dovato, Cabenuva |
| Janssen Scientific Affairs, LLC | $309.21 | 2023 | Symtuza, Prezista |
| Gilead Sciences, INC. | $295.37 | 2021-2025 | Biktarvy |
| Otsuka America Pharmaceutical, INC. | $105.78 | 2024-2025 | Rexulti |
| Lundbeck LLC | $85.89 | 2024-2025 | Rexulti |
| Novo Nordisk INC | $58.73 | 2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $33.62 | 2021-2025 | |
| Antares Pharma, INC. | $25.62 | 2025 | Xyosted |
| Lilly USA, LLC | $22.25 | 2025 | Zepbound, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $18.93 | 2025 | Trintellix |
| Phadia US INC. | $18.13 | 2021 | |
| Napo Pharmaceuticals INC | $13.33 | 2025 | Mytesi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.